.406 Ventures, a Boston, MA-based venture capital firm investing in early-stage innovative enterprise technology companies, announced the promotion of Payal Agrawal Divakaran to Principal and the hiring of Rob McCall as Senior Analyst.
Divakaran is actively involved with portfolio companies Axial Healthcare, AbilTo, CloudHealth Technologies, Jisto, Lexumo, and Redox. She received her MBA with Distinction at Harvard Business School, co-founded SpotRocket to allow job-seeking students to discover startups, and spent time in Corporate Development at Eventbrite.
Prior to receiving her MBA, Divakaran was an Associate at Spectrum Equity and started her career in technology investment banking at J.P. Morgan.
Rob McCall has been supporting the investment team across all of .406’s investment verticals, as well as running the Student Fellows program with partner Graham Brooks. He is currently actively involved in portfolio companies Simon Data and Terbium Labs. Prior to joining, McCall worked for .406-backed startup MineralTree and was a mid-market Account Manager at EMC2. He received a BA in Psychology, and minors in Economics and Environmental Science and Policy from Duke University.
Led by co-founders and managing partners Maria Cirino and Liam Donohue, .406 leads, or co-leads, first institutional investment rounds in Enterprise IT companies. The firm, which has celebrated its 10th year of activity earlier in 2016, has raised ~$650M across four funds, investing in 45 companies and creating $5B in enterprise value.